RET Is Dispensable for Maintenance of Midbrain Dopaminergic Neurons in Adult Mice

Glial cell-line derived neurotrophic factor (GDNF)-mediated RET tyrosine kinase signaling is implicated in the survival of several PNS and CNS neuronal populations that are important in the pathogenesis of several disorders including Parkinson's disease and drug addiction. However, it has been difficult to study these processes and the physiological importance of this pathway in adult mice because of the neonatal lethality of Gdnf and Ret null mice. We report successful creation of RET conditional reporter mice to investigate postnatal physiologic roles of RET and monitor the fate of RET-expressing cell types. To delete RET specifically in dopaminergic neurons and determine the physiologic requirement of RET in the maintenance of substantia nigra compacta (SNC) and ventral tegmental area (VTA), we bred the RET conditional mice with mice that specifically express Cre from the dopamine transporter (Dat) locus. A detailed morphometric and biochemical analysis including dopaminergic neuron number and size in SNC and VTA, and fiber density in the striatum and nucleus accumbens, and dopamine levels indicate that RET is not required for providing global trophic support to midbrain dopaminergic neurons in adult mice. Furthermore, RET deficiency in these neurons does not cause major sensorimotor abnormalities. Hence our results support the idea that RET signaling is not critical for the normal physiology of the SNC and VTA in adult mice.

[1]  G. Yadid,et al.  Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats , 2005, Experimental Neurology.

[2]  D. Wozniak,et al.  Ataxia and Paroxysmal Dyskinesia in Mice Lacking Axonally Transported FGF14 , 2002, Neuron.

[3]  J. Feldon,et al.  Acoustic startle response, prepulse inhibition, and spontaneous locomotor activity in MPTP-treated mice , 2004, Behavioural Brain Research.

[4]  P. Janak,et al.  Glial Cell Line-Derived Neurotrophic Factor Mediates the Desirable Actions of the Anti-Addiction Drug Ibogaine against Alcohol Consumption , 2005, The Journal of Neuroscience.

[5]  J. Milbrandt,et al.  Neurturin Exerts Potent Actions on Survival and Function of Midbrain Dopaminergic Neurons , 1998, The Journal of Neuroscience.

[6]  V. D’Agati,et al.  Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. , 1996, Development.

[7]  R. Schwarting,et al.  MPTP Susceptibility in the Mouse: Behavioral, Neurochemical, and Histological Analysis of Gender and Strain Differences , 2000, Behavior genetics.

[8]  Mart Saarma,et al.  The GDNF family: Signalling, biological functions and therapeutic value , 2002, Nature Reviews Neuroscience.

[9]  J. Bloch,et al.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.

[10]  Maureen P. Boyle,et al.  Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults , 2004, Neurobiology of Disease.

[11]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  Patrik Brundin,et al.  Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice , 2005, Behavioural Brain Research.

[13]  J. Milbrandt,et al.  Critical and distinct roles for key RET tyrosine docking sites in renal development. , 2006, Genes & development.

[14]  G. Paratcha,et al.  The Neural Cell Adhesion Molecule NCAM Is an Alternative Signaling Receptor for GDNF Family Ligands , 2003, Cell.

[15]  G. Yadid,et al.  Transplantation of glial cell line‐derived neurotrophic factor‐expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self‐administration in rats , 2003, The European journal of neuroscience.

[16]  I. Date,et al.  GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice , 1998, Neuroreport.

[17]  J. Saurat,et al.  Glial Cell-Line Derived Neurotrophic Factor-Mediated RET Signaling Regulates Spermatogonial Stem Cell Fate1 , 2006, Biology of reproduction.

[18]  N. Volkow,et al.  The neuroscience of addiction , 2005, Nature Neuroscience.

[19]  B. Hoffer,et al.  Glial cell line-derived neurotrophic factor receptor α1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles , 1999, Neuroscience.

[20]  S. Totterdell,et al.  Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment , 2001, Neuroscience.

[21]  Hideki Enomoto,et al.  The GDNF family ligands and receptors — implications for neural development , 2000, Current Opinion in Neurobiology.

[22]  Hideki Enomoto,et al.  GDNF availability determines enteric neuron number by controlling precursor proliferation , 2003, Development.

[23]  Zuo-ping Xie,et al.  GDNF augments survival and differentiation of TH‐positive neurons in neural progenitor cells , 2004, Cell biology international.

[24]  J. Sanes,et al.  Cerebellar Synaptic Defects and Abnormal Motor Behavior in Mice Lacking α- and β-Dystrobrevin , 2006, The Journal of Neuroscience.

[25]  T. Beach,et al.  Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease , 1998, Brain Research.

[26]  J. Milbrandt,et al.  RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. , 2001, Development.

[27]  J. Zimmer,et al.  Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP+ toxicity by GDNF , 2005, The European journal of neuroscience.

[28]  R. Burke Ontogenic cell death in the nigrostriatal system , 2004, Cell and Tissue Research.

[29]  Y. Imai,et al.  Rat primary cultured microglia express glial cell line-derived neurotrophic factor receptors , 1999, Neuroscience Letters.

[30]  M. Zigmond,et al.  Forced Nonuse in Unilateral Parkinsonian Rats Exacerbates Injury , 2002, The Journal of Neuroscience.

[31]  G. Martin,et al.  An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination , 1998, Nature Genetics.

[32]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[33]  D. Brooks,et al.  Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease , 2003, Nature Medicine.

[34]  J. Milbrandt,et al.  Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis , 2004, Development.

[35]  Jonathan Salcedo,et al.  Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein , 2004, The Journal of Neuroscience.

[36]  L. Chia,et al.  Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice , 1998, Neuroscience Letters.

[37]  B. Hoffer,et al.  Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.

[38]  E. Nestler,et al.  Role for GDNF in Biochemical and Behavioral Adaptations to Drugs of Abuse , 2000, Neuron.

[39]  P. Bickford,et al.  Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta , 2005, The Journal of Neuroscience.

[40]  K. Unsicker,et al.  Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of α‐synuclein in the substantia nigra , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  Frank Costantini,et al.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret , 1994, Nature.

[42]  M. Saarma,et al.  GDNF Family Neurotrophic Factor Signaling: Four Masters, One Servant? , 1999, Molecular and Cellular Neuroscience.

[43]  G. Gerhardt,et al.  Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. , 2005, Journal of neurosurgery.

[44]  René Hen,et al.  Targeted gene expression in dopamine and serotonin neurons of the mouse brain , 2005, Journal of Neuroscience Methods.

[45]  J. Cooper,et al.  CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  E. Pehek,et al.  Selective subregional dopamine depletions in the rat caudate‐putamen following nigrostriatal lesions , 1992, Synapse.

[47]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[48]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.